查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439256

血液淨化設備 - 全球市場考量、競爭狀況、市場預測 (2030)

Blood Purification Devices/Equipment/Methods - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球血液淨化設備市場規模預計2023年將達到49億美元，2030年將達到62.7億美元，2024-2030年預測期間複合年增長率為4.19%。血液淨化設備的需求主要是由於慢性腎臟病（CKD）和終末期腎病（ESRD）患者數量的增加，導致腎病的高血壓、糖尿病患者數量迅速增加。由於血液淨化設備的採用增加，損害、血液透析技術的進步以及產品批准的增加正在擴大。

血液淨化裝置市場動態

慢性腎病（CKD）和末期腎病（ESRD）患者數量的增加是血液淨化設備市場的主要驅動因素之一。研究表明，慢性病往往影響世界上約 10% 的成年人口。已知糖尿病、高血壓、血管疾病和腎絲球腎炎等疾病會導致慢性腎臟疾病。除上述原因外，腎絲球腎炎和間質性腎炎也是低收入國家慢性腎臟病的主要原因。根據這項研究，CKD 往往會影響某些年齡層和性別，但在老年人中更為常見，各種研究表明，全球 64 歲以上人群中 CKD 盛行率為 23%。約為 36%。

除了上述數量外，International Society of Nephrology也宣布，到2022年，全球將有8.5億人患有某種形式的腎臟疾病。

糖尿病和高血壓等慢性腎病危險因子的增加正在推動對血液淨化設備的需求。根據International Diabetes Federation（2021）發布的數據，2021年約有5.37億20歲至79歲的成年人患有糖尿病。

然而，血液淨化設備的高成本以及與血液淨化程序相關的風險預計將限制預測期內的市場成長。

血液淨化設備細分市場分析

按血液淨化設備市場的類型細分，便攜式血液淨化設備類別預計將成為市場上最大的成長領域。原因是便攜式血液淨化設備具有的優勢，例如佔用空間較小，並且易於移動設備，尤其是在重症監護病房中。因此，醫療保健專業人員可能會首選它們來治療患者。

便攜式血液淨化裝置可以讓患者在接受透析的同時繼續進行日常活動，放鬆或完全消除食物和液體限制以及減輕藥物負擔，從而改善患者的生活品質。例如，2022年3月12日，Baxter宣布美國FDA核准AK 98血液透析機。這項新技術為透析提供者提供了緊湊、便攜且易於使用的系統。該設備具有穩定的底座設計，便於濃縮液和便攜式逆滲透膜的儲存和運輸。隨著此類設備的批准，未來對便攜式設備的需求預計會增加，因為與固定式血液淨化設備相比，它們往往能提供更好的結果。這導致了便攜式血液淨化設備市場的成長。

北美預計將主導整個血液淨化設備市場。

在所有地區中，北美估計在血液淨化設備市場中佔據最大份額。這一優勢是由於腎臟疾病的盛行率不斷上升以及患有肥胖和高血壓等生活方式相關疾病的患者人數不斷增加。此外，廣泛的產品開發活動和家用透析機的日益普及預計將進一步推動北美地區的產品需求。除上述因素外，新產品的推出和批准以及美國特定手術成本的廣泛覆蓋預計將進一步推動北美血液淨化設備市場的發展。

根據美國疾病管制與預防中心所引用的數據（2023），估計美國約有 15% 的成年人患有慢性腎臟病。此外，估計顯示女性的 CKD 發病率略高於男性。隨著時間的推移，慢性腎臟病會進展為腎衰竭並需要透析。因此，患者人數的增加表明腎臟疾病負擔的增加，對應於需要透析作為維持生命治療的潛在患者群體的存在，從而對國內產品需求產生積極影響。

本報告研究和分析了全球血液淨化設備市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第1章 血液淨化裝置報告簡介

第2章 血液淨化裝置概要

  • 調查範圍
  • 市場概況
  • 競爭評估

第3章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章 血液淨化設備主要因素分析

  • 血液淨化設備市場驅動因素
    • 慢性腎病（CKD）和末期腎病（ESRD）患者數量增加
    • 導致腎臟損傷的高血壓和糖尿病患者迅速增加
    • 血液透析技術進步
  • 血液淨化裝置市場限制因素及挑戰
    • 血液淨化設備成本高
    • 與血液淨化程序相關的風險
  • 血液淨化裝置市場機會
    • 血液淨化裝置應用於各領域。

第5章 血液淨化裝置的波特五力分析

第6章 血液淨化裝置市場佈局

  • 按產品類型
    • 血液透析機
    • 血液過濾裝置
    • 連續性腎臟替代療法 (CRRT) 裝置
    • 血液灌流裝置
    • 血漿置換裝置
  • 按類型
    • 固定式
    • 便攜的
  • 按最終用戶
    • 醫院
    • 診斷中心
    • 其他
  • 按地區
    • 北美血液淨化裝置市場規模（2021-2030）
    • 歐洲血液淨化設備市場規模（2021-2030）
    • 亞太地區血液淨化設備市場規模（2021-2030）
    • 其他地區血液淨化裝置市場規模（2021-2030年）

第7章 血液淨化裝置企業及產品簡介

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Fresenius SE and Co. KGaA
  • Baxter International Inc.
  • Infomed SA
  • Jafron Biomedical Co., Ltd.
  • Kaneka Corporation
  • Nikkiso Co, ltd.
  • SWS Medical Group
  • Medtronic, Inc.
  • CytoSorbents Europe GmbH
  • Spectral Medical Inc
  • Haemonetics Corporation
  • Ceus Corporation
  • ExThera Medical Corporation

第8章 KOL觀點

第9章 專案方法

第10章 DelveInsight服務內容

第11章 關於 DelveInsight

第12章 免責聲明與聯絡我們

Product Code: DIMDCL0044

Blood Purification Devices Market By Product Type (Hemodialysis Device, Blood Filtration Device, Continuous Renal Replacement Therapy (CRRT) Device, Hemoperfusion Device, and Plasma Exchange Device), Type (Portable And Stationary), Application (Diagnostics and Therapeutics) End-User (Hospitals, Dialysis Centres and Others), and Geography is expected to grow at a steady CAGR Forecast till 2030 owing to an Increase In the number of cases for hypertension and the rise observed in the chronic kidney disease (CKD) and end-stage renal disease patients

The global blood purification devices market was valued at USD 4.90 billion in 2023, growing at a CAGR of 4.19% during the forecast period from 2024 to 2030, to reach USD 6.27 billion by 2030. The demand for blood purification devices is primarily witnessing growth on account of the increase in the number of Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) patients, the surge in the cases of hypertension and diabetes leading to kidney disorders, technological advancements in hemodialysis, increasing product approvals, and increase in adoption of blood purification equipment.

Blood Purification Devices Market Dynamics:

The rising number of patients suffering from Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) is one of the major reasons for driving the Blood Purification Devices market. As per research studies, chronic disease tends to affect about 10% of the world's adult population. Several conditions comprising diabetes, hypertension, vascular disease, and glomerulonephritis are known to cause chronic renal disease. Even in low-income countries, besides the above-known causes, glomerulonephritis and interstitial nephritis are the major cause of most chronic kidney disease cases. According to this research, although CKD tends to affect certain age groups and sexes, it is more prevalent in the case of aged individuals, and various studies have estimated that the worldwide prevalence of CKD is 23-36% in people aged >=64.

In addition to the above data, the International Society of Nephrology stated that, worldwide, 850 million people were living with some form of kidney disease in 2022.

The increasing number of risk factors including diabetes, hypertension, and others associated with causing chronic kidney disease are going to assist in the growing demand for blood purification devices. The data published by International Diabetes Federation 2021 stated that around 537 million adults aged between 20 and 79 years were suffering from diabetes in 2021.

However, the high cost of blood purification equipment and the risks associated with blood purification procedures are expected to limit the market growth over the forecast period.

Blood Purification Devices Market Segment Analysis:

Blood Purification Devices Market by Product Type (Hemodialysis Device, Blood Filtration Device, Continuous Renal Replacement Therapy (CRRT) Device, Hemoperfusion Device, and Plasma Exchange Device), Type (Portable and Stationary), Application (Diagnostics and Therapeutics), End-User (Hospitals, Dialysis Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type segment of the blood purification devices market, the portable blood purification devices category is anticipated to be the largest growing segment in the market. The reason is the advantages that are offered by the portable type of blood purification devices such as less utilization of space and ease related to movement of the devices, specifically in critical care units. Therefore, these are most likely preferred by healthcare professionals for the treatment of patients.

Portable blood purification devices can potentially improve the quality of patient life by allowing them to continue with their daily activities of life while undergoing dialysis as well as by loosening-or removing entirely-dietary and fluid restrictions and reducing pill burden. For instance, on March 12, 2022, Baxter announced the US FDA approval of the AK 98 Hemodialysis Machine. The latest technology provides a compact, portable, and easy-to-use system for dialysis providers. The machine has a stable base design which allows for easy concentrate or portable reverse osmosis storage and transportation of the machine. Due to the approval of such devices, the demand for portable devices is expected to rise in the future as they tend to offer better results in comparison to stationary blood purification devices. This will lead to the growth of the portable blood purification devices market.

North America is expected to dominate the overall Blood Purification Devices Market:

Among all the regions, North America is estimated to account for the largest share of the blood purification devices market. This domination is due to the rising prevalence of kidney disorders, and the rising population of patients suffering from lifestyle disorders such as obesity and hypertension. Moreover, extensive efforts in product developmental activities and the growing popularity of home-based dialysis devices are further expected to drive product demand in the North American region. In addition to the above-stated factors, the new product launches and approvals and the extensive coverage of procedural costs specifically in the United States are expected to further boost the market for blood purification devices in North America.

As per the data cited by the Centers for Disease Control and Prevention (2023), about 15% of adults in the United States (accounting for approximately 37 million people) are estimated to have chronic kidney disease. According to further estimates presented by the source, women are slightly more affected by CKD as compared to men. CKD, over time, progresses to kidney failure thereby necessitating the need for dialysis. Therefore, the growing burden of kidney disorders indicated by the increase in patient population corresponds to the presence of a potential patient population that may require dialysis as a life-supporting therapy, thus positively influencing the product demand in the nation.

Additionally, another key factor that is thought to contribute to the increasing prevalence of kidney disorders is the surge in obesity in the country's population. For instance, as per the data provided by the CDC (2023), in 2017-2018, the obesity prevalence in the country was 42.4%. Obesity has been established as a formidable risk factor for the development of kidney disease. It has been studied that in patients affected by obesity, a compensatory mechanism of hyperfiltration is said to take place to meet the increased metabolic demands due to a gain in body weight. This can massively increase the intraglomerular pressure which may damage the kidney structure and escalate the risk of developing CKD in the long term.

Thus, the interplay of all the previous factors is likely to contribute to the market growth of blood purification devices in the United States as well as the North America region as a whole during the forecast period.

Blood Purification Devices Market Key Players:

Some of the key market players operating in the blood purification devices market include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE and Co. KGaA, Infomed SA, Jafron Biomedical Co., Ltd., Kaneka Corporation, Nikkiso Co, ltd. and SWS Medical Group, CytoSorbents Europe GmbH, Spectral Medical Inc., Haemonetics Corporation, Medtronic, Cerus Corporation, ExThera Medical Corporation and others.

Blood Purification Devices Market Recent Developmental Activities:

In December 2022, Medtronic launched the first neonatal dialysis machine in the US.

In June 2022, the New York-based startup, Qidni Labs, a company pursuing waterless and mobile blood purification systems, announced that they are looking forward to human trials in 2022 following a successful animal study.

In March 2022, Baxter received FDA clearance for its latest, portable dialysis machine designed to connect directly with electronic medical records for patients' prescriptions and treatment data.

Key Takeaways from the Blood Purification Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global blood purification devices market.

Various opportunities available for the other competitor in the blood purification devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for market growth in the coming future?

Target Audience who can be benefited from this Blood Purification Devices Market Report Study

Blood Purification Devices providers

Research organizations and consulting companies

Blood Purification Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders

Various End-users who want to know more about the blood purification devices market and the latest technological developments in the blood purification devices market.

Frequently Asked Questions for Blood Purification Devices Market:

1. What are Blood Purification Devices?

Blood Purification is a procedure that involves the withdrawal of blood from the patient's body into a device or equipment to eliminate the impurities and pump them back into the body. The blood purification devices are similar to that of dialysis equipment. These devices use thin fibers for capturing and removing viruses and help in filtering blood.

2. What is the market for global blood purification devices?

The global blood purification devices market was valued at USD 4.90 billion in 2023, growing at a CAGR of 4.19% during the forecast period from 2024 to 2030, to reach USD 6.27 billion by 2030.

3. What are the drivers for global blood purification devices?

The major drivers driving the demand for global blood purification devices are the increase in the number of chronic kidney disease and end-stage renal disease patients, the increasing number of cases of hypertension and diabetes leading to kidney disorders, technological advancements in hemodialysis, the rise in the number of product approvals by FDA and increase in adoption of blood purification equipment.

4. Who are the key players operating in the global blood purification devices?

Some of the key market players operating in the blood purification devices market include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE and Co. KGaA, Infomed SA, Jafron Biomedical Co., Ltd., Kaneka Corporation, and others.

5. Which region has the highest share in the blood purification devices market?

North America is expected to dominate the overall blood purification devices during the forecast period, 2024 to 2030. This domination is due to the rising prevalence of CKD and ESRD in patients along with the increased awareness regarding blood purification devices and the rapid expansion of healthcare infrastructure.

Table of Contents

1. Blood Purification Devices Report Introduction

2. Blood Purification Devices Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Blood Purification Devices Key Factors Analysis

  • 4.1. Blood Purification Devices Market Drivers
    • 4.1.1. Increase in number of Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) patients
    • 4.1.2. Surge in the cases of hypertension and diabetes leading to kidney disorders
    • 4.1.3. Technological advancements in hemodialysis
  • 4.2. Blood Purification Devices Market Restraints and Challenges
    • 4.2.1. High cost of blood purification devices
    • 4.2.2. Risks associated with the blood purification procedures
  • 4.3. Blood Purification Devices Market Opportunities
    • 4.3.1. Blood Purification Devices have applications in various domains

5. Blood Purification Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Blood Purification Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Hemodialysis Device
    • 6.1.2. Blood Filtration Device
    • 6.1.3. Continuous Renal Replacement Therapy (CRRT) Device
    • 6.1.4. Hemoperfusion Device
    • 6.1.5. Plasma Exchange Device
  • 6.2. By Type
    • 6.2.1. Stationary
    • 6.2.2. Portable
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Diagnostic Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Blood Purification Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.1. France Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Blood Purification Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.1. China Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Blood Purification Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Blood Purification Devices Market Size in USD million (2021-2030)

7. Blood Purification Devices Company and Product Profiles

  • 7.1. Asahi Kasei Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. B. Braun Melsungen AG
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Fresenius SE and Co. KGaA
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Baxter International Inc.,
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Infomed SA
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Jafron Biomedical Co., Ltd.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Kaneka Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Nikkiso Co, ltd.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. SWS Medical Group
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Medtronic, Inc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. CytoSorbents Europe GmbH
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Spectral Medical Inc
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Haemonetics Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Ceus Corporation
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. ExThera Medical Corporation
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Blood Purification Devices Market in Global (2021-2030)
  • Table 3: Blood Purification Devices Market in Global by Type (2021-2030)
  • Table 4: Blood Purification Devices Market in Global by Product Type (2021-2030)
  • Table 5: Blood Purification Devices Market in Global by End-User (2021-2030)
  • Table 6: Blood Purification Devices Market in Global by Geography (2021-2030)
  • Table 7: Blood Purification Devices Market in North America (2021-2030)
  • Table 8: Blood Purification Devices Market in the US (2021-2030)
  • Table 9: Blood Purification Devices Market in Canada (2021-2030)
  • Table 10: Blood Purification Devices Market in Mexico (2021-2030)
  • Table 11: Blood Purification Devices Market in Europe (2021-2030)
  • Table 12: Blood Purification Devices Market in France (2021-2030)
  • Table 13: Blood Purification Devices Market in Germany (2021-2030)
  • Table 14: Blood Purification Devices in the United Kingdom (2021-2030)
  • Table 15: Blood Purification Devices Market in Italy (2021-2030)
  • Table 16: Blood Purification Devices Market in Spain (2021-2030)
  • Table 17: Blood Purification Devices Market in Rest of Europe (2021-2030)
  • Table 18: Blood Purification Devices in Asia-Pacific (2021-2030)
  • Table 19: Blood Purification Devices Market in China (2021-2030)
  • Table 20: Blood Purification Devices Market in Japan (2021-2030)
  • Table 21: Blood Purification Devices Market in India (2021-2030)
  • Table 22: Blood Purification Devices Market in Australia (2021-2030)
  • Table 23: Blood Purification Devices Market in South Korea (2021-2030)
  • Table 24: Blood Purification Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Blood Purification Devices Market in the Rest of the World (2021-2030)
  • Table 26: Blood Purification Devices Market in the Middle East (2021-2030)
  • Table 27: Blood Purification Devices Market in Africa (2021-2030)
  • Table 28: Blood Purification Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Blood Purification Devices Market in Global (2021-2030)
  • Figure 3: Blood Purification Devices Market in Global by Type (2021-2030)
  • Figure 4: Blood Purification Devices Market in Global by Product Type (2021-2030)
  • Figure 5: Blood Purification Devices Market in Global by End-User (2021-2030)
  • Figure 6: Blood Purification Devices Market in Global by Geography (2021-2030)
  • Figure 7: Blood Purification Devices Market in North America (2021-2030)
  • Figure 8: Blood Purification Devices Market in the US (2021-2030)
  • Figure 9: Blood Purification Devices Market in Canada (2021-2030)
  • Figure 10: Blood Purification Devices Market in Mexico (2021-2030)
  • Figure 11: Blood Purification Devices Market in Europe (2021-2030)
  • Figure 12: Blood Purification Devices Market in France (2021-2030)
  • Figure 13: Blood Purification Devices Market in Germany (2021-2030)
  • Figure 14: Blood Purification Devices Market in the United Kingdom (2021-2030)
  • Figure 15: Blood Purification Devices Market in Italy (2021-2030)
  • Figure 16: Blood Purification Devices Market in Spain (2021-2030)
  • Figure 17: Blood Purification Devices Market in Rest of Europe (2021-2030)
  • Figure 18: Blood Purification Devices Market in Asia-Pacific (2021-2030)
  • Figure 19: Blood Purification Devices Market in China (2021-2030)
  • Figure 20: Blood Purification Devices Market in Japan (2021-2030)
  • Figure 21: Blood Purification Devices Market in India (2021-2030)
  • Figure 22: Blood Purification Devices Market in Australia (2021-2030)
  • Figure 23: Blood Purification Devices Market in South Korea (2021-2030)
  • Figure 24: Blood Purification Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Blood Purification Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Blood Purification Devices Market in the Middle East (2021-2030)
  • Figure 27: Blood Purification Devices Market in Africa (2021-2030)
  • Figure 28: Blood Purification Devices Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 32: PORTER'S Five Force Analysis